TrialScientific reports2020

Medium cut-off dialyzer improves erythropoiesis stimulating agent resistance in a hepcidin-independent manner in maintenance hemodialysis patients: results from a randomized controlled trial.

Jeong-Hoon Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.